WHO ICTRP trial
A Phase II Trial of Erlotinib as first line therapy in Non- Small Cell Lung…
EUCTR2007-001264-72-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-001264-72-GB |
|---|---|
| Public title | A Phase II Trial of Erlotinib as first line therapy in Non- Small Cell Lung Cancer over-expressing EGFR - Study of targeted Erlotinib treatment for Non-small cell lung cancer |
| Scientific title | A Phase II Trial of Erlotinib as first line therapy in Non- Small Cell Lung Cancer over-expressing EGFR - Study of targeted Erlotinib treatment for Non-small cell lung cancer |
| Primary sponsor | Oxford Radcliffe Hospitals NHS Trust |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Stage IIIb/IV non-small cell lung cancer (NSCLC) tumours that over-express EGFR MedDRA version: 9.1 Level: LLT Classification code 10025054 Term: Lung cancer non-small cell stage IIIB MedDRA version: 9.1 Level: LLT Classification code… |
| Interventions | Trade Name: Tarceva Product Name: Tarceva Product Code: erotinib Pharmaceutical Form: Film-coated tablet INN or Proposed INN: erotinib CAS Number: 183319-69-9 Concentration unit: mg milligram(s) Concentration type: equal Concentration… |
| Registration date | Apr 17, 2007 |
| Target size | 35 |
| Secondary IDs | ORH/PID/5298;not applicable |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: